Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay Sosenko

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Current Diabetes Reports|March 20, 2003
The epidemiology of neuropathic foot ulcers in individuals with diabetesJay Sosenko
Professional Ethics (Gainesville, Fla.)|October 8, 2004
Unusually difficult challenges in human-subjects researchArturo Brito, Jay Sosenko, Kenneth W Goodman
Nature Clinical Practice. Endocrinology & Metabolism|May 1, 2008
Prevention of type 1 diabetes: the time has comeJennifer Sherr, Jay Sosenko, Jay S Skyler, et al.
Diabetes|December 5, 2020
Baseline Assessment of Circulating MicroRNAs Near Diagnosis of Type 1 Diabetes Predicts Future Stimulated Insulin SecretionIsaac Snowhite, Ricardo Pastori, Jay Sosenko, et al.
Diabetes Care|June 7, 2019
The Influence of Type 2 Diabetes-Associated Factors on Type 1 DiabetesMaria J Redondo, Carmella Evans-Molina, Andrea K Steck, et al.
Diabetologia|May 14, 2017
Association of serum microRNAs with islet autoimmunity, disease progression and metabolic impairment in relatives at risk of type 1 diabetesIsaac V Snowhite, Gloria Allende, Jay Sosenko, et al.
Diabetologia|October 13, 2021
HOMA2-B enhances assessment of type 1 diabetes risk among TrialNet Pathway to Prevention participantsJamie L Felton, David Cuthbertson, Megan Warnock, et al.
Diabetes Care|July 27, 2016
Do Electrochemiluminescence Assays Improve Prediction of Time to Type 1 Diabetes in Autoantibody-Positive TrialNet Subjects?Alexandra Fouts, Laura Pyle, Liping Yu, et al.
The Journal of Clinical Endocrinology and Metabolism|May 7, 2022
Oral Glucose Tolerance Test Measures of First-phase Insulin Response and Their Predictive Ability for Type 1 DiabetesDavid A Baidal, Megan Warnock, Ping Xu, et al.
Diabetes Technology & Therapeutics|March 19, 2016
ECL-IAA and ECL-GADA Can Identify High-Risk Single Autoantibody-Positive Relatives in the TrialNet Pathway to Prevention StudyAndrea K Steck, Alexandra Fouts, Dongmei Miao, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Current Diabetes Reports|March 20, 2003
The epidemiology of neuropathic foot ulcers in individuals with diabetesJay Sosenko
Professional Ethics (Gainesville, Fla.)|October 8, 2004
Unusually difficult challenges in human-subjects researchArturo Brito, Jay Sosenko, Kenneth W Goodman
Nature Clinical Practice. Endocrinology & Metabolism|May 1, 2008
Prevention of type 1 diabetes: the time has comeJennifer Sherr, Jay Sosenko, Jay S Skyler, et al.
Diabetes|December 5, 2020
Baseline Assessment of Circulating MicroRNAs Near Diagnosis of Type 1 Diabetes Predicts Future Stimulated Insulin SecretionIsaac Snowhite, Ricardo Pastori, Jay Sosenko, et al.
Diabetes Care|June 7, 2019
The Influence of Type 2 Diabetes-Associated Factors on Type 1 DiabetesMaria J Redondo, Carmella Evans-Molina, Andrea K Steck, et al.
Diabetologia|May 14, 2017
Association of serum microRNAs with islet autoimmunity, disease progression and metabolic impairment in relatives at risk of type 1 diabetesIsaac V Snowhite, Gloria Allende, Jay Sosenko, et al.
Diabetologia|October 13, 2021
HOMA2-B enhances assessment of type 1 diabetes risk among TrialNet Pathway to Prevention participantsJamie L Felton, David Cuthbertson, Megan Warnock, et al.
Diabetes Care|July 27, 2016
Do Electrochemiluminescence Assays Improve Prediction of Time to Type 1 Diabetes in Autoantibody-Positive TrialNet Subjects?Alexandra Fouts, Laura Pyle, Liping Yu, et al.
The Journal of Clinical Endocrinology and Metabolism|May 7, 2022
Oral Glucose Tolerance Test Measures of First-phase Insulin Response and Their Predictive Ability for Type 1 DiabetesDavid A Baidal, Megan Warnock, Ping Xu, et al.
Diabetes Technology & Therapeutics|March 19, 2016
ECL-IAA and ECL-GADA Can Identify High-Risk Single Autoantibody-Positive Relatives in the TrialNet Pathway to Prevention StudyAndrea K Steck, Alexandra Fouts, Dongmei Miao, et al.
Pageof 3